Specialist Pharmacy (9010630) - Improvement action plan

The pharmacy has undertaken a risk assessment for its prescribing service. But the risk assessment does not consider individual medicines supplied by the pharmacy or its subscription model. And the assessment does not make it clear which mitigation corresponds to which risk. The pharmacy has also undertaken a compounding risk assessment. But it cannot sufficiently show that it has considered individual risks and how to mitigate each one. This risk assessment is overdue for review, and it does not cover all areas of the service. For example, it does not cover verification of the preparation method, calculation verification, product‐specific risks, or relevant staff skills. It also does not include finding out if equivalent relevant licensed products exist and are available.

The prescribing services risk assessment is currently in draft mode and being reviewed and finalised by the Superintendent. The template will be revised to be concise and make clear each mitigation against risk and consider each unlicensed product formulation and the subscription model. The template of the prescribing risk assessment will be updated to make clear which mitigation corresponds to which risk. All risk assessments including the compounding risk assessment regarding verification of the preparation method, calculation verification, product‐specific risks, or relevant staff skills to be made clear, in-date and submitted.